HOME > News 2021

Text Size
SML

Print

News 2021

Readers are advised that the press releases and other information posted on this site are current only on their original publication date. Please note that such press releases and other information may now be outdated or rendered inaccurate due to passage of time or subsequent material changes in facts and circumstance.

Oct. 1, 2021 Company Announcement of Official LinkedIn Account
Sep. 10, 2021 Company Regarding the Recent Novel Coronavirus Infection at an ESPEC Subsidiary
Aug. 31, 2021 IR Financial Results Briefing for 1st Quarter FY2021 (Abridged version)
Aug. 30, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC
Aug. 25, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC
Aug. 20, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC and its Subsidiary
Aug. 6, 2021 IR Consolidated Financial Results for the Three Months Ended June 30, 2021
Aug. 4, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)(Updated on: Aug. 4, 2021)
Jul. 29, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC
Jul. 14, 2021 IR Corporate Governance Report
Jul. 14, 2021 IR Notice Concerning Results and Completion of Acquisition of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3) (PDF277KB)
Jul. 14, 2021 IR Notice Concerning Acquisition of Own Shares and Repurchase of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3) (PDF400KB)
Jun. 25, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)(Updated on: Jun. 25, 2021)
Jun. 7, 2021 IR Financial Results Briefing for FY2020 (Abridged version)
May. 26, 2021 IR Notice of Revision of Basic Policy on Establishing Internal Control System (PDF298KB)
May. 25, 2021 IR NOTICE OF THE 68TH ORDINARY GENERAL MEETING OF SHAREHOLDERS
May. 24, 2021 IR Notice of Differences between Consolidated Financial Forecast Figures and Financial Results for Fiscal 2020 and Resolution of Dividend of Surplus(PDF202KB)
May. 24, 2021 IR Consolidated Financial Results for the Fiscal Year Ended March 31, 2021
Apr. 28, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)(Updated on: Apr. 28, 2021)
Apr. 7, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)(Updated on: Apr. 7, 2021)
Mar. 25, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)(Updated on: Mar. 25, 2021)
Mar. 4, 2021 IR Financial Results Briefing for 3rd Quarter FY2020 (Abridged version)
Feb. 18, 2021 IR Summary of Financial Results (Consolidated) for the Third Quarter of Fiscal 2020 Ending March 31, 2021
Feb. 18, 2021 IR Notice of Revisions of Consolidated Full-Year Financial Forecast and Year-End Dividend Forecast for Fiscal 2020(PDF218KB)
Feb. 9, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC
Feb. 9, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)(Updated on: Feb. 9, 2021)
Jan. 25, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC
Jan. 25, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)(Updated on: Jan. 25, 2021)
Jan. 14, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC
Jan. 14, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)(Updated on: Jan. 14, 2021)
Jan. 7, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)(Updated on: Jan. 7, 2021)